Tradestie Institutional Equity Comparison Engine
MYO vs SGHT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGHT Overall Edge
SGHT Captures Institutional Edge (3โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sight Sciences, Inc. Common Stock (SGHT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MYO trades at N/M Forward P/E with -21.8% operating margin (+22.2% YoY revenue) versus SGHT at N/M Forward P/E and -20.2% operating margin (+25.2% YoY). In options structure, MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro) against SGHT sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MYO N/M vs SGHT N/M Fwd P/E
Growth & Margin Winner
SGHT
Op Margin -21.8% vs -20.2% ยท YoY +22.2% vs +25.2%
Momentum & Technical Winner
SGHT
1Y +12.3% vs +46.9% ยท 52W Pos 16% vs 83%
Options & Structure Winner
SGHT
UNCLASSIFIED (81st %ile IV) vs CONSOLIDATION (8th %ile IV)
MYO
NYSE American
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap
$33.7M
1M Return
-33.52%
1Y Return
+12.3%
Forward P/E
N/M
Unified AI Score
40.1 / 100
SELL
Tech 25.0
Fund 43.0
Flow 58.0
Mom 59.0
SGHT
NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.18
-4.14% 1D
Market Cap
$590.2M
1M Return
+11.99%
1Y Return
+46.9%
Forward P/E
N/M
Unified AI Score
53.2 / 100
HOLD
Tech 39.0
Fund 54.0
Flow 70.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MYO +12.3%
SGHT +46.9%
Spread: +34.6 pp (SGHT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MYO Revenue | SGHT Revenue | MYO Op. Margin | SGHT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -430.8% | N/A | MYO |
| FY2019 | $0M | N/A | -281.3% | N/A | MYO |
| FY2020 | $10M | $30M | -138.5% | -116.5% | SGHT |
| FY2021 | $10M | $50M | -74.1% | -105.2% | MYO |
| FY2022 | $20M | $70M | -68.6% | -117.7% | MYO |
| FY2023 | $20M | $80M | -42.8% | -70.7% | MYO |
| FY2024 | $30M | $80M | -19.1% | -63.3% | MYO |
| FY2025 | $40M | $80M | -35.2% | -48.0% | MYO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MYO | SGHT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $33.7M | $590.2M | Larger Scale | SGHT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +22.2% | +25.2% | Higher Growth | SGHT |
| Operating Margin (TTM) Profitability | -21.8% | -20.2% | Higher Margin | SGHT |
| Net Profit Margin Profitability | -33.1% | -32.1% | Higher Margin | SGHT |
| Return on Equity (ROE) Capital Efficiency | -173.5% | -50.1% | Higher ROE | SGHT |
| 52-Week Range Position Momentum | 16% ($1โ$2) | 83% ($3โ$12) | Stronger Trend | SGHT |
| Beta / 30D Volatility Risk Regime | 2.22ฮฒ ยท 107% Vol | 1.09ฮฒ ยท 48% Vol | Lower Realized Risk | SGHT |
| Unified Institutional Score Composite Signal | 40.1 / 100 (SELL) | 53.2 / 100 (HOLD) | Higher Composite | SGHT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MYO vs SGHT Buy Guide
MYO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
81st %ile
IV Regime
Extreme (>80th %ile)
SGHT
CONSOLIDATION
37d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MYO nor SGHT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.